United States Pharmaceuticals

Veradermics, Incorporated (MANE)

Track

Track

Veradermics, Incorporated experienced significant insider trading activity recently, with 23 sell transactions totaling over $265 million. Key executives, including the CEO and CTO, offloaded shares following the August 11th earnings report. These divestments occurred amid a 5.2% decline in stock performance over the last quarter, reflecting substantial liquidation by major stakeholders and corporate leadership.
Ticker: MANE Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Veradermics, Incorporated. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
MONTANOVA CAPITAL, LLC See footnotes Non-Executive Director
Transaction date
Sale
Price
134.52
Quantity 9,034 +19.4%
Value US$2,458,349
3.4
MONTANOVA CAPITAL, LLC See footnotes Non-Executive Director
Transaction date
Sale
Price
469.29
Quantity 86,064 -30.7%
Value US$4,470,267
Durso Timothy August Chief Technical Officer Officer
Transaction date
Sale
Price
111.28
Quantity 161 -0.2%
Value US$17,916
Durso Timothy August Chief Technical Officer Officer
Transaction date
Sale
Price
109.34
Quantity 2,348 -2.9%
Value US$256,730
Durso Timothy August Chief Technical Officer Officer
Transaction date
Sale
Price
108.38
Quantity 16,767 -17.2%
Value US$1,817,207
Durso Timothy August Chief Technical Officer Officer
Transaction date
Sale
Price
107.52
Quantity 16,306 -14.3%
Value US$1,753,221
Durso Timothy August Chief Technical Officer Officer
Transaction date
Sale
Price
106.71
Quantity 7,918 -6.5%
Value US$844,930
Waldman Reid Alexander Chief Executive Officer Executive Director
Transaction date
Sale
Price
111.28
Quantity 249 -0.1%
Value US$27,709
Waldman Reid Alexander Chief Executive Officer Executive Director
Transaction date
Sale
Price
109.38
Quantity 3,000 -1.7%
Value US$328,140
Waldman Reid Alexander Chief Executive Officer Executive Director
Transaction date
Sale
Price
108.45
Quantity 27,490 -13.6%
Value US$2,981,290
Waldman Reid Alexander Chief Executive Officer Executive Director
Transaction date
Sale
Price
107.53
Quantity 25,234 -11.1%
Value US$2,713,412
Waldman Reid Alexander Chief Executive Officer Executive Director
Transaction date
Sale
Price
106.72
Quantity 11,527 -4.8%
Value US$1,230,161
Timothy Durso Officer Officer
Transaction date
Proposed sale
Price
111.28
Quantity 87,000
Value US$9,681,360
Reid Alexander Waldman CEO
Transaction date
Proposed sale
Price
111.28
Quantity 135,000
Value US$15,022,800
4.3
CHILDS JOHN W Non-Executive Director
Transaction date
Sale
Price
108.24
Quantity 5,000 -2.5%
Value US$541,200
4.3
CHILDS JOHN W Non-Executive Director
Transaction date
Sale
Price
107.23
Quantity 80,000 -28.7%
Value US$8,578,400
4.3
CHILDS JOHN W Non-Executive Director
Transaction date
Sale
Price
106.14
Quantity 15,000 -5.1%
Value US$1,592,100
AMZL, LP Shareholder
Transaction date
Proposed sale
Price
108.95
Quantity 104,587
Value US$11,394,754
3.6
ENRIGHT PATRICK G Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 882,353 +75.3%
Value US$15,000,001
3.6
ENRIGHT PATRICK G Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 192,647 +8.0%
Value US$3,274,999
4.1
Coric Vlad Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 58,823 +22.6%
Value US$999,991
4.1
Coric Vlad Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 58,823 +22.6%
Value US$999,991
4.3
CHILDS JOHN W Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 294,117 +15.4%
Value US$4,999,989
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-21 2026-08-19 S Sale
3.4
MONTANOVA CAPITAL, LLC

See footnotes

Non-Executive Director
9,034 +19.4%
134.52
US$2,458,349 		9,034 +19.4% 134.52 US$2,458,349
2026-08-21 2026-08-19 S Sale
3.4
MONTANOVA CAPITAL, LLC

See footnotes

Non-Executive Director
86,064 -30.7%
469.29
US$4,470,267 		86,064 -30.7% 469.29 US$4,470,267
2026-08-19 2026-08-19 PrS Proposed sale
Averill Master Fund, Ltd.

Affiliate
11,508
408.01
US$256,828 		11,508 408.01 US$256,828
2026-08-19 2026-08-19 PrS Proposed sale
Averill Madison Master Fund, Ltd.

Affiliate
59,399
107.25
US$6,370,543 		59,399 107.25 US$6,370,543
2026-08-18 2026-08-17 S Sale
Durso Timothy August

Chief Technical Officer

Officer
161 -0.2%
111.28
US$17,916 		161 -0.2% 111.28 US$17,916
2026-08-18 2026-08-17 S Sale
Durso Timothy August

Chief Technical Officer

Officer
2,348 -2.9%
109.34
US$256,730 		2,348 -2.9% 109.34 US$256,730
2026-08-18 2026-08-17 S Sale
Durso Timothy August

Chief Technical Officer

Officer
16,767 -17.2%
108.38
US$1,817,207 		16,767 -17.2% 108.38 US$1,817,207
2026-08-18 2026-08-17 S Sale
Durso Timothy August

Chief Technical Officer

Officer
16,306 -14.3%
107.52
US$1,753,221 		16,306 -14.3% 107.52 US$1,753,221
2026-08-18 2026-08-17 S Sale
Durso Timothy August

Chief Technical Officer

Officer
7,918 -6.5%
106.71
US$844,930 		7,918 -6.5% 106.71 US$844,930
2026-08-18 2026-08-17 S Sale
Waldman Reid Alexander

Chief Executive Officer

Executive Director
249 -0.1%
111.28
US$27,709 		249 -0.1% 111.28 US$27,709
2026-08-18 2026-08-17 S Sale
Waldman Reid Alexander

Chief Executive Officer

Executive Director
3,000 -1.7%
109.38
US$328,140 		3,000 -1.7% 109.38 US$328,140
2026-08-18 2026-08-17 S Sale
Waldman Reid Alexander

Chief Executive Officer

Executive Director
27,490 -13.6%
108.45
US$2,981,290 		27,490 -13.6% 108.45 US$2,981,290
2026-08-18 2026-08-17 S Sale
Waldman Reid Alexander

Chief Executive Officer

Executive Director
25,234 -11.1%
107.53
US$2,713,412 		25,234 -11.1% 107.53 US$2,713,412
2026-08-18 2026-08-17 S Sale
Waldman Reid Alexander

Chief Executive Officer

Executive Director
11,527 -4.8%
106.72
US$1,230,161 		11,527 -4.8% 106.72 US$1,230,161
2026-08-17 2026-08-17 PrS Proposed sale
Timothy Durso

Officer

Officer
87,000
111.28
US$9,681,360 		87,000 111.28 US$9,681,360
2026-08-17 2026-08-17 PrS Proposed sale
Reid Alexander Waldman

CEO
135,000
111.28
US$15,022,800 		135,000 111.28 US$15,022,800
2026-08-14 2026-08-12 PrS Proposed sale
4.3
John W. Childs 2013 Revocable Trust

Affiliate
100,000
109.05
US$10,905,000 		100,000 109.05 US$10,905,000
2026-08-14 2026-08-12 S Sale
4.3
CHILDS JOHN W
Non-Executive Director
5,000 -2.5%
108.24
US$541,200 		5,000 -2.5% 108.24 US$541,200
2026-08-14 2026-08-12 S Sale
4.3
CHILDS JOHN W
Non-Executive Director
80,000 -28.7%
107.23
US$8,578,400 		80,000 -28.7% 107.23 US$8,578,400
2026-08-14 2026-08-12 S Sale
4.3
CHILDS JOHN W
Non-Executive Director
15,000 -5.1%
106.14
US$1,592,100 		15,000 -5.1% 106.14 US$1,592,100
2026-08-14 2026-08-12 PrS Proposed sale
4.3
John W. Childs 2013 Revocable Trust

Affiliate
100,000
109.05
US$10,905,000 		100,000 109.05 US$10,905,000
2026-08-12 2026-08-12 PrS Proposed sale
AMZL, LP

Shareholder
104,587
108.95
US$11,394,754 		104,587 108.95 US$11,394,754
2026-08-12 2026-08-12 PrS Proposed sale
SR One Capital Fund II Aggregator, LP

Shareholder
217,162
108.95
US$23,659,800 		217,162 108.95 US$23,659,800
2026-02-09 2026-02-06 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
19,338 +3.9%
36.55
US$706,804 		19,338 +3.9% 36.55 US$706,804
2026-02-09 2026-02-06 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
11,183 +2.3%
35.97
US$402,253 		11,183 +2.3% 35.97 US$402,253
2026-02-09 2026-02-05 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
16,563 +3.5%
39.80
US$659,207 		16,563 +3.5% 39.80 US$659,207
2026-02-09 2026-02-05 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
17,835 +3.9%
38.67
US$689,679 		17,835 +3.9% 38.67 US$689,679
2026-02-09 2026-02-05 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
38,771 +9.3%
37.63
US$1,458,953 		38,771 +9.3% 37.63 US$1,458,953
2026-02-09 2026-02-05 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
19,199 +4.8%
36.93
US$709,019 		19,199 +4.8% 36.93 US$709,019
2026-02-09 2026-02-05 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
3,832 +1.0%
36.07
US$138,220 		3,832 +1.0% 36.07 US$138,220
2026-02-05 2026-02-05 B Purchase
Longitude Capital Partners V, LLC
Large shareholder
882,353 +75.3%
17.00
US$15,000,001 		882,353 +75.3% 17.00 US$15,000,001
2026-02-05 2026-02-05 B Purchase
Longitude Capital Partners V, LLC
Large shareholder
192,647 +8.0%
17.00
US$3,274,999 		192,647 +8.0% 17.00 US$3,274,999
2026-02-05 2026-02-05 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director Large shareholder
882,353 +75.3%
17.00
US$15,000,001 		882,353 +75.3% 17.00 US$15,000,001
2026-02-05 2026-02-05 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director Large shareholder
192,647 +8.0%
17.00
US$3,274,999 		192,647 +8.0% 17.00 US$3,274,999
2026-02-05 2026-02-05 B Purchase
4.1
Coric Vlad
Non-Executive Director
58,823 +22.6%
17.00
US$999,991 		58,823 +22.6% 17.00 US$999,991
2026-02-05 2026-02-05 B Purchase
4.1
Coric Vlad
Non-Executive Director
58,823 +22.6%
17.00
US$999,991 		58,823 +22.6% 17.00 US$999,991
2026-02-05 2026-02-05 B Purchase
4.3
CHILDS JOHN W
Non-Executive Director
294,117 +15.4%
17.00
US$4,999,989 		294,117 +15.4% 17.00 US$4,999,989
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
3,178 +0.8%
38.90
US$123,624 		3,178 +0.8% 38.90 US$123,624
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
4,453 +1.2%
38.09
US$169,615 		4,453 +1.2% 38.09 US$169,615
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
9,168 +2.4%
37.11
US$340,224 		9,168 +2.4% 37.11 US$340,224
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
2,519 +0.7%
36.27
US$91,364 		2,519 +0.7% 36.27 US$91,364
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
1,835 +0.5%
34.74
US$63,748 		1,835 +0.5% 34.74 US$63,748
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
1,720 +0.5%
34.25
US$58,910 		1,720 +0.5% 34.25 US$58,910
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
18,489 +0.5%
38.90
US$719,222 		18,489 +0.5% 38.90 US$719,222
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
25,908 +0.7%
38.09
US$986,836 		25,908 +0.7% 38.09 US$986,836
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
53,344 +1.5%
37.11
US$1,979,596 		53,344 +1.5% 37.11 US$1,979,596
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
14,659 +0.4%
36.27
US$531,682 		14,659 +0.4% 36.27 US$531,682
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
10,676 +0.3%
34.74
US$370,884 		10,676 +0.3% 34.74 US$370,884
2026-02-09 2026-02-04 B Purchase
3.4
SUVRETTA CAPITAL MANAGEMENT, LLC
Non-Executive Director Large shareholder
10,004 +0.3%
34.25
US$342,637 		10,004 +0.3% 34.25 US$342,637
Explore more

More insider trading research around Veradermics, Incorporated

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America